Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China S Hoehl, H Rabenau, A Berger, M Kortenbusch, J Cinatl, D Bojkova, ... New England Journal of Medicine 382 (13), 1278-1280, 2020 | 763 | 2020 |
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies A Wilhelm, M Widera, K Grikscheit, T Toptan, B Schenk, C Pallas, ... MedRxiv, 2021.12. 07.21267432, 2021 | 364 | 2021 |
Omicron BA. 1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes J Quandt, A Muik, N Salisch, BG Lui, S Lutz, K Krüger, AK Wallisch, ... Science immunology 7 (75), eabq2427, 2022 | 161 | 2022 |
The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro N Kohmer, T Toptan, C Pallas, O Karaca, A Pfeiffer, S Westhaus, ... Journal of clinical medicine 10 (2), 328, 2021 | 158 | 2021 |
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread? T Toptan, L Eckermann, AE Pfeiffer, S Hoehl, S Ciesek, C Drosten, ... Journal of Clinical Virology 135, 104713, 2021 | 136 | 2021 |
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA. 1 and BA. 2 by convalescent and vaccine serum and monoclonal antibodies A Wilhelm, M Widera, K Grikscheit, T Toptan, B Schenk, C Pallas, ... EBioMedicine 82, 2022 | 109 | 2022 |
Optimized qRT-PCR approach for the detection of intra-and extra-cellular SARS-CoV-2 RNAs T Toptan, S Hoehl, S Westhaus, D Bojkova, A Berger, B Rotter, ... International journal of molecular sciences 21 (12), 4396, 2020 | 85 | 2020 |
Assessment of SARS-CoV-2 transmission on an international flight and among a tourist group S Hoehl, O Karaca, N Kohmer, S Westhaus, J Graf, U Goetsch, S Ciesek JAMA network open 3 (8), e2018044-e2018044, 2020 | 68 | 2020 |
Omicron BA. 2 breakthrough infection enhances cross-neutralization of BA. 2.12. 1 and BA. 4/BA. 5 A Muik, BG Lui, M Bacher, AK Wallisch, A Toker, A Finlayson, K Krüger, ... Science immunology 7 (77), eade2283, 2022 | 59 | 2022 |
Limited neutralization of authentic severe acute respiratory syndrome coronavirus 2 variants carrying E484K in vitro M Widera, A Wilhelm, S Hoehl, C Pallas, N Kohmer, T Wolf, HF Rabenau, ... The Journal of infectious diseases 224 (7), 1109-1114, 2021 | 46 | 2021 |
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings M Widera, S Westhaus, HF Rabenau, S Hoehl, D Bojkova, J Cinatl Jr, ... Medical microbiology and immunology 210 (4), 235-244, 2021 | 40 | 2021 |
Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro M Widera, A Wilhelm, S Hoehl, C Pallas, N Kohmer, T Wolf, HF Rabenau, ... MedRxiv, 2021.02. 24.21252372, 2021 | 38 | 2021 |
Novel multiple swab method enables high efficiency in SARS‐CoV‐2 screenings without loss of sensitivity for screening of a complete population M Schmidt, S Hoehl, A Berger, H Zeichhardt, K Hourfar, S Ciesek, ... Transfusion 60 (10), 2441-2447, 2020 | 35 | 2020 |
Yellow fever: Integrating current knowledge with technological innovations to identify strategies for controlling a re-emerging virus RDV Kleinert, E Montoya-Diaz, T Khera, K Welsch, B Tegtmeyer, S Hoehl, ... Viruses 11 (10), 960, 2019 | 31 | 2019 |
Thirty years of CMV seroprevalence—a longitudinal analysis in a German university hospital S Hoehl, A Berger, S Ciesek, HF Rabenau European Journal of Clinical Microbiology & Infectious Diseases 39, 1095-1102, 2020 | 30 | 2020 |
Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs) N Kohmer, HF Rabenau, S Hoehl, M Kortenbusch, S Ciesek, A Berger Journal of virological methods 291, 114102, 2021 | 24 | 2021 |
At-home self-testing of teachers with a SARS-CoV-2 rapid antigen test to reduce potential transmissions in schools: Results of the SAFE School Hesse Study S Hoehl, B Schenk, O Rudych, S Göttig, I Foppa, N Kohmer, O Karaca, ... medRxiv, 2020.12. 04.20243410, 2020 | 24* | 2020 |
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity A Muik, BG Lui, J Quandt, H Diao, Y Fu, M Bacher, J Gordon, A Toker, ... Cell Reports 42 (8), 2023 | 20 | 2023 |
Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation J Quandt, A Muik, N Salisch, BG Lui, S Lutz, K Krüger, AK Wallisch, ... bioRxiv, 2022.04. 01.486695, 2022 | 19 | 2022 |
Self-collected samples to detect SARS-CoV-2: direct comparison of Saliva, Tongue Swab, Nasal Swab, chewed cotton pads and gargle lavage N Kohmer, L Eckermann, B Böddinghaus, U Götsch, A Berger, ... Journal of Clinical Medicine 10 (24), 5751, 2021 | 17 | 2021 |